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Higher plants have two metabolic pathways for
isoprenoid biosynthesis: the cytosolic mevalonate (MVA)
pathway and the plastidal non-mevalonate (MEP) pathway.
Despite the compartmentalization of these two pathways,
metabolic flow occurs between them. However, little is known
about the mechanisms that regulate the two pathways and the
metabolic cross-talk. To identify such regulatory mechanisms,
we isolated and characterized the Arabidopsis T-DNA
insertion mutant lovastatin insensitive 1 (loi1), which is
resistant to lovastatin and clomazone, inhibitors of the
MVA and MEP pathways, respectively. The accumulation
of the major products of these pathways, i.e. sterols and
chlorophyll, was less affected by lovastatin and clomazone,
respectively, in loi1 than in the wild type. Furthermore, the
3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR)
activity analysis showed higher activity of HMGR in loi1-1
treated with lovastatin than that in the WT. We consider that
the lovastatin-resistant phenotype of loi1-1 was derived from
this post-transcriptional up-regulation of HMGR. The LOI1
gene encodes a novel pentatricopeptide repeat (PPR) protein.
PPR proteins are thought to regulate the expression of genes
encoded in organelle genomes by post-transcriptional regula-
tion in mitochondria or plastids. Our results demonstrate that
LOI1 is predicted to localize in mitochondria and has the
ability to bind single-stranded nucleic acids. Our investigation
revealed that the post-transcriptional regulation of mitochon-
drial RNA may be involved in isoprenoid biosynthesis in both
the MVA and MEP pathways.
Keywords: Arabidopsis — 3-Hydroxy-3-methylglutaryl
coenzyme A reductase (HMGR) — Isoprenoid
biosynthesis — Lovastatin — Mevalonate (MVA)
pathway — Pentatricopeptide repeat (PPR).
Abbreviations: DIG, digoxigenin; DMAPP, dimethylallyl
diphosphate; DTT, dithiothreitol; DXS, 1-deoxy-D-xylulose 5-
phosphate synthase; GFP, green fluorescent protein; GST,
glutathione S-transferase; HMGR, 3-hydroxy-3-methylglutaryl
coenzyme A reductase; HMGS, HMG-CoA synthase; IPP,
isopentenyl diphosphate; loi, lovastatin insensitive; MEP,
2-C-methyl-D-erythritol-4-phosphate; MVA, mevalonate; PBS,
phosphate-buffered saline; PPR, pentatricopeptide repeat;
RT–PCR, reverse transcription–PCR; ssRNA, single-stranded
RNA; WT, wild type.
Introduction
Unlike most organisms, plants produce a wide variety
of isoprenoids. They are derived from common C5 isoprene
units: isopentenyl diphosphate (IPP) and its isomer
dimethylallyl diphosphate (DMAPP), produced via two
pathways, the cytosolic mevalonate (MVA) pathway and
the plastidal 2-C-methyl-D-erythritol-4-phosphate (MEP)
pathway. Labeling experiments have shown that sesquiter-
penes, cis-cytokinins, triterpenes, sterols, brassinosteroids,
dolichol and mitochondrial ubiquinone side chains mainly
comprise isoprene units produced via the MVA pathway
(Newman and Chappell 1999, Kasahara et al. 2004),
whereas gibberellins, ABA, trans-cytokinins, carotenoids,
chlorophyll side chains and plastoquinone side chains
comprise mainly isoprene units produced via the MEP
pathway (Lichtenthaler 1999, Kasahara et al. 2004) (Fig. 1).
Despite the compartmentalization of these two pathways,
metabolic flow between them has been reported in recent
studies (Kasahara et al. 2002, Nagata et al. 2002,
Hemmerlin et al. 2003). Therefore, the production of IPP
and DMAPP is defined as the activity of the MVA
pathway, the MEP pathway, and the metabolic flow
between these pathways. However, we have little knowledge
of the mechanisms that regulate these complex biosynthetic
pathways or their metabolic cross-talk.
Lovastatin, also referred to as mevinolin, is a
specific inhibitor of 3-hydroxy-3-methylglutaryl coenzyme
A reductase (HMGR), which is thought to be a rate-limiting
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enzyme of the MVA pathway (Schaller et al. 1995,
Masferrer et al. 2002, Suzuki et al. 2004). Lovastatin
treatment leads to a reduction in MVA pathway products,
such as sterols, and the inhibition of growth (Bach and
Lichtenthaler 1983). rim1, an allelic mutant of phyB that is
resistant to mevinolin and fosmidomycin (an inhibitor of
the MEP pathway), was screened based on the phenotype of
true leaf development with mevinolin treatment (Rodrı́guez-
Concepción et al. 2004). Rodrı́guez-Concepción et al. (2004)
speculated that HMGR is up-regulated and leads to
mevinolin resistance in rim1 because light down-regulates
HMGR (Learned 1996), and that enhanced intake from
MVA-derived isoprenoid precursors to the plastid causes
fosmidomycin resistance. The dramatic phenotype of
HMGR inhibitor-treated seedlings or hmg1 mutation is
the severe inhibition of cell elongation. As a result, the root
lengths of these seedlings are shortened markedly (Suzuki
et al. 2004). We screened lovastatin-resistant mutants using
root length as a screening marker to identify new regulatory
mechanisms involved in plant isoprenoid biosynthesis.
Here, we report the isolation and characterization of
loi1 (lovastatin insensitive 1), which has longer roots than
the wild type (WT) under lovastatin treatment. The loi1
plants showed resistance not only to blockage of the MVA
pathway, but also to blockage of the MEP pathway.
Because LOI1 encoded a novel pentatricopeptide repeat
(PPR) protein, thought to be a regulator of organelle
gene expression, and is localized in the mitochondria,
we propose that the novel potential regulatory mechanism
of plant isoprenoid biosynthesis is associated with the
mitochondria.
Results
Isolation of lovastatin insensitive 1-1 (loi1-1)
We examined Arabidopsis development under various
concentrations of lovastatin (a specific inhibitor of HMGR)
to determine the most appropriate concentration for
screening lovastatin-resistant mutants. Blocking the
MVA pathway by treatment with mevinolin (lovastatin)
results in the inhibition of root elongation, contraction of
the cotyledons and arrested development of true leaves
in Arabidopsis (Rodrı́guez-Concepción et al. 2004).
We observed similar phenotypes in seedlings grown
with 300 nM lovastatin. In particular, root elongation was
markedly inhibited (data not shown). Therefore, we used
root length as a marker of sensitivity to lovastatin at
300 nM.
We screened approximately 3000 of the RIKEN GSC
activation tagging T-DNA lines (Nakazawa et al. 2003)
for lovastatin-resistant mutants. After germination on MS
plates containing 300 nM lovastatin for 14 d, seedlings
that had longer roots than those of the WT were transferred
to soil and allowed to develop and set seed. The individual
that showed the least sensitivity to lovastatin was
designated as lovastatin insensitive 1-1 (loi1-1; Fig. 2A).
The lovastatin sensitivity of F1 plants generated by
backcrossing loi1-1 with the WT was comparable with
that of the WT, suggesting that loi1-1 was a recessive
mutant.
Lower lovastatin sensitivity in the loi1-1 mutant than in
the WT
Root elongation (defined as the root length of
2-week-old seedlings grown with various concentrations
of the inhibitor relative to those grown without the inhibitor)
in WT plants grown with 300 nM lovastatin was
strongly reduced. In contrast, the root elongation of treated
loi1-1 plants was less affected (Figs. 2A, 3). Root elongation
in loi1-1 was reduced by concentrations of lovastatin
41 mM (Fig. 3).
Furthermore, we observed lovastatin-induced root
growth arrest under a microscope. In the treated WT
plants, lateral root growth was arrested, and tumor-like
abnormal shapes appeared. In contrast, the roots of treated
loi1-1 seedlings showed normal development (Fig. 2B).
We observed longitudinal sections of the roots of loi1-1 and





























Fig. 1 Isoprenoid biosynthesis in the plant cell. The MEP
pathway, localized to plastids, is shown in the box. Genes
mentioned in the text are indicated in bold and italics; inhibitors
are underlined. White arrows indicate metabolic flow between the
cytosol and plastids, and from the cytosol to mitochondria. HMGR,
3-hydroxy-3-methylglutaryl CoA reductase; DXS, 1-deoxy-D-xylu-
lose 5-phosphate synthase; DXR, DX reductase; IPP, isopentenyl
diphosphate; MVA, mevalonate; MEP, 2-C-methyl-D-erythritol-4-
phosphate.






/pcp/article/48/2/322/2329769 by guest on 08 Septem
ber 2021
treated WT were abnormal, the root tip of treated loi1-1 did
not show any abnormality (Fig. 2C). A tumor-like
abnormal shape was also observed in the upper region
of treated WT roots, but not in treated loi1-1 roots
(data not shown). We considered that the tumor-like
shape may be the arrested growth of lateral roots.
The loi1-1 mutant required treatment with higher
concentrations of lovastatin than the WT for the other
lovastatin-sensitive phenotypes to appear, i.e. contracted
cotyledons and arrested development of true leaves
(Fig. 2A). These results indicate that loi1-1 was more
resistant to lovastatin than the WT.
Lower sensitivity to lovastatin in loi1-1 than in the WT in
terms of the total amount of sterols
Because sterol (major product of the MVA pathway)-
defective mutants showed abnormalities in root
elongation and formation, there may be a threshold
level of sterols required for root elongation and formation
(Diener et al. 2000, Carland et al. 2002, Schaller 2004,
Suzuki et al. 2004). Thus, the effect of lovastatin treatment
on the amount of sterols in loi1-1 and the WT was
examined. Total sterols were extracted from 2-week-old
loi1-1 and WT seedlings grown with various concentrations
of lovastatin. Although the amount of sterols in
the WT was markedly reduced by lovastatin, that in
loi1-1 was less affected (Fig. 4). There was no difference
in sterol composition between loi1-1 and the WT
(Supplementary data).







Fig. 2 Characteristic phenotypes of the loi1 mutant. Seedlings grown on MS solid medium supplemented with or without inhibitor under
long-day conditions. (A) Two-week-old seedlings of the wild type (WT), loi1-1, loi1-2 and 35S::LOI1 in loi1-1 (left to right) grown with (þ)
or without () 300 nM lovastatin. Bar¼ 1 cm. (B) Roots of 2-week-old WT (top) and loi1-1 (bottom) seedlings grown with (þ) or without ()
300 nM lovastatin. Arrows indicate the tumor-like abnormal shape. Bar¼ 1mm. (C) Longitudinal sections of the root tip of 2-week-old WT
(top) and loi1-1 (bottom) seedlings grown with (þ) or without () 300 nM lovastatin. Bar¼ 100mM. (D) One-week-old WT, loi1-1, loi1-2
and 35S::LOI1 in loi1-1 (left to right) seedlings grown with (þ) or without () 300 nM clomazone. Bar¼ 5mm. (E) Electron microscopy






























Fig. 3 Effect of lovastatin treatment on root elongation in the WT
and loi1-1. Relative root elongation in WT (black rhombuses) and
loi1-1 (black squares) seedlings grown on MS solid medium
supplemented with the indicated concentrations of lovastatin.
Means and standard deviations were calculated from at least three
independent experiments using approximately 20 individuals in
each experiment.
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Lovastatin resistance of loi1-1 seedlings can be explained by
the post-transcriptional up-regulation of HMGR
Whereas the loi1-1 mutant showed lower sensitivity
to lovastatin than the WT, no significant differences in
squalestatin (an inhibitor of squalene synthase) sensitivity
were found between loi1-1 and WT plants (data not shown).
These results suggest that the metabolic flow upstream of
squalene synthase may be up-regulated in loi1-1, at least in
the presence of lovastatin. This up-regulation may result
from either the increased activity of the MVA pathway itself
or the up-regulation of the metabolic flow of prenyl
diphosphates between the plastid and the cytosol. Because
lovastatin is an HMGR inhibitor, an increase in HMGR
expression could result in resistance to lovastatin (Re et al.
1995, Rodrı́guez-Concepción et al. 2004). We examined
mRNA and activity of HMGR in WT and loi1-1 plants
grown with or without lovastatin. Reverse transcription–
PCR (RT–PCR) analysis showed that the expression levels
of HMG1 and HMG2 genes, which encode HMGR in
Arabidopsis, were not affected in loi1-1 plants (Fig. 5A).
Although HMGR activity in loi1-1 plants without lovasta-
tin was comparable with that in the WT without lovastatin,
the HMGR activity in loi1-1 grown with lovastatin was
clearly higher than that in the WT grown with lovastatin
(Fig. 5B). The observed phenotype of lovastatin resistance
may therefore be derived from the enhanced activation
of HMGR.
Lower clomazone sensitivity in the loi1-1 mutant than in
the WT
To investigate whether the metabolic flow of the MEP
pathway was altered in loi1-1 plants, as a first approach we
fed clomazone to loi1-1 plants. Clomazone is thought to be
a specific inhibitor of 1-deoxy-D-xylulose 5-phosphate
synthase (DXS) (Mueller et al. 2000), which is the first
committed step of the MEP pathway (Dubey et al. 2003).
Clomazone treatment leads to a reduction in the MEP
pathway products such as chlorophyll side chains and
carotenoids, and causes an albino phenotype (Zeidler et al.
2000). A 1-week-old WT seedling grown with 300 nM
clomazone showed an albino phenotype and a deficiency of
normal thylakoid stacking in the chloroplasts (Fig. 2D, E).
In contrast, loi1-1 was able to produce green leaves and
normal chloroplasts in the presence of 300 nM clomazone
(Fig. 2D, E). In fact, clomazone treatment resulted in a
more marked decrease in total chlorophyll mass in the WT
than in loi1-1 (Fig. 6). These results suggest the potential
activation of the MEP pathway in loi1-1, at least in the
presence of clomazone. Because clomazone inhibits DXS,



































Fig. 5 Expression of HMGR. (A) RT–PCR
analysis of HMG1 and HMG2 using cDNA
made from total RNA extracted from 2-week-
old seedlings grown on MS solid medium
supplemented with (þ) or without () 300 nM
lovastatin. (B) Relative HMGR activity in the
WT, WT grown with lovastatin, loi1-1,
and loi1-1 grown with lovastatin (left to
right). Activity in the WT was given a value
of 1. ER protein fractions were extracted
from 12-day-old seedlings grown on MS
solid medium supplemented with or without
300 nM lovastatin.



























Fig. 4 Effect of lovastatin treatment on sterol contents. Relative
sterol contents in WT (black rhombuses) and loi1-1 (black squares)
seedlings grown on MS solid medium supplemented with the
indicated concentrations of lovastatin. Means and standard
deviations were calculated from at least four independent
experiments. The total amounts of sterols in the WT and loi1-1
grown without lovastatin were 366 131.6 mg 100mg1 DW and
290 111.9 mg 100mg1 DW, respectively. Detailed sterol profiles
are found in the Supplementary data.
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clomazone. We examined mRNA and protein levels of
DXS in the WT and loi1-1 treated or not with clomazone.
RT–PCR analysis showed that the expression levels of
DXS1, DXS2 and DXS3 genes, which encode DXS
in Arabidopsis, were not increased in loi1-1 (Fig. 7A).
An immunoblot analysis with anti-DXS antibody showed
nearly equal amounts of DXS in the WT and loi1-1 treated
with clomazone (Fig. 7B).
Identification of the LOI1 gene At4g14850
The loi1-1 mutant was screened using T-DNA activa-
tion tagging lines (Nakazawa et al. 2003). The T-DNA
marker (hygromycin resistance) and lovastatin resistance
were co-segregated in the F2 population.
We investigated the location of the T-DNA insertion
in loi1-1 using plasmid rescue. Two different genomic
fragments were obtained as the left border flanking
sequence of the T-DNA. Both of these were almost identical
to the sequence of the first exon of the At4g14850 gene,
and the direction of these fragments was opposite. These
results suggest that the T-DNA inverted repeat was inserted
in the At4g14850 gene (Fig. 8A).
We examined the phenotype of another allele, i.e. loi1-2





































Fig. 6 Effect of clomazone treatment on chlorophyll content.
Chlorophyll content of the WT, WT grown with clomazone, loi1-1,
and loi1-1 grown with clomazone (left to right). Chlorophyll was
extracted from 1-week-old seedlings grown on MS solid medium
supplemented with or without 300 nM clomazone under long-day
conditions.
– + – +












Fig. 7 Expression of DXS. (A) RT–PCR analysis of DXS1, DXS2
and DXS3 using cDNA made from total RNA extracted from
1-week-old seedlings grown on MS solid medium supplemented
with (þ) or without () 300 nM clomazone. (B) Immunoblotting
analysis of DXS using total protein fractions extracted from 1-week-
old seedlings grown on MS solid medium supplemented with (þ) or


















Fig. 8 Structure and expression of the LOI1 gene and RNA
binding ability of LOI1 protein. (A) Structure of the LOI1 gene. The
inserted T-DNA for each allele is flagged. Numbers are assigned to
the initiation codon. (B) RNA gel blot analysis of the At4g14850
gene; rRNA stained with ethidium bromide is shown as a loading
control. (C) RNA binding assay of GST–LOI1, and GST–StSGT as
the negative control. GST–LOI1 expressed in E. coli and purified
protein were incubated with the indicated Sepharose- or agarose-
bound RNA homopolymers: poly(A), poly(U), poly(G) and poly(C).
Bound proteins were resolved by SDS–PAGE and analyzed by
immunoblotting with anti-GST antibody. The lane total represents
approximately 10% of the input material used in each binding
reaction.
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purchased from the SALK Institute, La Jolla, CA, USA),
grown with 300 nM lovastatin or 300 nM clomazone.
The sensitivity of loi1-2 to these inhibitors was comparable
with that of loi1-1 (Fig. 2A, D).
To investigate At4g14850 gene expression, total RNA
was prepared from seedlings of the WT, loi1-1 and loi1-2,
and RNA gel blot analysis was performed. The At4g14850
transcript was detected in the WT, but not in loi1-1 or loi1-2
(Fig. 8B). F1 plants generated from crossing loi1-1 and
loi1-2 showed the loi1 phenotype (data not shown).
Furthermore, we performed a complementation test of the
At4g14850 gene. The lovastatin and clomazone sensitivity
of loi1-1 seedlings that overexpressed At4g14850 cDNA was
comparable with that of the WT, indicating that the
At4g14850 gene can complement the loi1 phenotype
(Fig. 2A, D). These results demonstrated that the LOI1
gene was At4g14850. Organ-specific LOI1 gene expression
analysis by RT–PCR demonstrated that the LOI1 gene was
expressed ubiquitously (data not shown).
The LOI1 gene encodes a putative protein that has a
pentatricopeptide repeat motif
LOI1 encodes a putative protein with 684 amino acids.
LOI1 was predicted to be a member of the PPR family.
Some PPR proteins are predicted to be targeted to
mitochondria or chloroplasts and probably to bind to
organelle RNA, taking part in the regulation of organelle
gene expression (Small and Peeters 2000).
We investigated whether the LOI1 protein has the
ability to bind single-stranded RNA (ssRNA). Glutathione
S-transferase (GST)-fused LOI1 protein expressed in
Escherichia coli was extracted and purified. First, we
confirmed the binding ability of purified recombinant
GST–LOI1 to ssRNA using North-Western analysis
(Suzuki et al. 2000). Next, we examined the preferred
sequence of LOI1 in a binding assay using RNA
homopolymers. Purified recombinant GST–LOI1 and
GST were incubated with agarose- or Sepharose-bound
RNA homopolymers. After washing with binding buffer,
bound proteins were resolved by SDS–PAGE and analyzed
by immunoblotting with anti-GST antibody. The LOI1
protein bound preferentially to poly(G) homoribopolymers
(Fig. 8C), suggesting that the target of LOI1 may be a
G-rich sequence.
To examine the cellular localization of LOI1, we
performed a transient expression assay in onion epidermal
cells using the LOI1 protein fused to green fluorescent
protein (GFP) recombinant protein driven by the 35S
promoter. Because GFP fluorescence was rarely detected
when the full length of LOI1 was used, we tried using an
N-terminal LOI1 fragment (Met1– Pro39) and detected
fluorescence (Fig. 9). This demonstrated that the GFP
fusion proteins are targeted to the mitochondria, according
to the co-localization of GFP images with those stained
with mitochondrion-specific dye (MitoTracker Orange) in
the same cells (Fig. 9). This indicates that LOI1 may localize
to the mitochondria.
Discussion
loi1 is a novel mutant showing resistance to the blockage of
the MVA and MEP pathway
Prenyl diphosphate is a component unit of a variety of
isoprenoids. Because plants have two prenyl diphosphate
biosynthetic pathways, the MVA and MEP pathways, the
original regulatory mechanism of prenyl diphosphate
biosynthesis may occur in plants. To identify regulators of
the MVA pathway, Arabidopsis activation tagging lines
were screened for mutants that displayed lower sensitivity to





Fig. 9 Localization of LOI1.
LOI1–GFP, N-terminus of LOI1 fused
to GFP (top); pTH38, mitochondrial
transit signal fused to GFP (bottom).
LOI1–GFP and pTH38 were transi-
ently expressed in epidermal cells of
onion transformed by particle bombard-
ment. Green fluorescence shows GFP,
red fluorescence shows mitochondria
stained by MitoTracker Orange, yellow
fluorescence shows images with the
two types of fluorescence merged
(left to right). Bar¼ 50 mm.
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isolating one mutant, loi1-1, that required higher concen-
trations of lovastatin than the WT for inhibition of root
elongation and formation, and arrested development of true
leaves (Fig. 2A, B). The cell size, shape and pattern in WT
roots treated with lovastatin were similar to those in roots
of mutants such as smt1 and hyd1, which are defective in
sterol production, the major MVA-derived products of
biosynthesis (Souter et al. 2002, Willemsen et al. 2003).
In contrast, the cell size, shape and pattern in loi1-1 roots
treated with lovastatin were normal (Fig. 2C). In addition,
loi1-1 showed lower sensitivity to lovastatin than did the
WT in its sterol contents (Fig. 4). Furthermore, the HMGR
activity analysis showed higher activity of HMGR in loi1-1
treated with lovastatin than in the WT (Fig. 5B).
We consider that the lovastatin-resistant phenotype
of loi1-1 was derived from this post-transcriptional
up-regulation of HMGR.
Recently, Rodrı́guez-Concepción and co-workers
reported resistant mutants against inhibitors for the
MVA/MEP pathway, i.e. rim1 (Rodrı́guez-Concepción
et al. 2004) and rif10 (Sauret-Güeto et al. 2006). The rim1
mutant is resistant to mevinolin (i.e. lovastatin) and
fosmidomycin [an inhibitor of 1-deoxy-D-xylulose
5-phosphate reductase (DX reductase); moreover, it is
allelic to phyB, and its resistance is caused by the
transcriptional and post-transcriptional up-regulation of
HMGR (Rodrı́guez-Concepción et al. 2004). On the other
hand, expression of the HMG1 and HMG2 genes was not
affected in loi1-1 (Fig. 5A). Thus, the mechanism of
lovastatin resistance in loi1 differs from that of mevinolin
resistance in rim1.
The loi1-1 seedlings were also resistant to clomazone.
While this suggests potential activation of the MEP pathway
in loi1-1 in the presence of clomazone (Fig. 2D), immuno-
blot analysis showed the nearly equal accumulation of DXS
in the WT and loi1-1 grown with or without clomazone
(Fig. 7B). Although rim1 was reported to be fosmidomycin
resistant, the transcriptional and post-transcriptional
up-regulation of DX reductase was not observed in this
mutant (Rodrı́guez-Concepción et al. 2004). Enhanced
import of MVA-derived prenyl diphosphates into the plastid
was proposed to account for the fosmidomycin-resistant
phenotype of rim1 (Rodrı́guez-Concepción et al. 2004).
However, because loi1-1 cla1-1 shows an albino phenotype
(data not shown), the clomazone-resistant phenotype of
loi1 may not be caused by metabolic flow from the MVA
pathway to the MEP pathway. Therefore, the mechanism of
clomazone resistance in loi1 also differs from that of
fosmidomycin resistance in rim1.
The rif10 mutant is fosmidomycin resistant. RIF10
is a polyribonucleotide phosphorylase localized in plastids.
It has been demonstrated that plastid RNA process-
ing is involved in plastid isoprenoid biosynthesis
(Sauret-Güeto et al. 2006). loi1 did not show fosmidomycin
resistance (unpublished data), indicating that loi1 shows
clomazone resistance by a mechanism that differs from that
of fosmidomycin resistance in rif10.
LOI1 encodes a novel PPR protein that may be localized in
mitochondria
Many genes (450) that are characterized by the
presence of tandem arrays of a PPR repeat have been
discovered by systematic screening of predicted Arabidopsis
proteins (Aubourg et al. 2000, Small and Peeters 2000, Lurin
et al. 2004). Some plastid PPR-defective mutants have been
isolated and analyzed, including crp1, which is involved
in the processing and translation of the pet gene in maize
(Fisk et al. 1999), as well as hcf152 (Meierhoff et al. 2003,
Nakamura et al. 2003) and crr4 (Kotera et al. 2005) in
Arabidopsis. Some mitochondrial PPR genes have been
isolated and characterized, such as the nuclear gene that
restores cytoplasmic male sterility mutants, which was
associated with aberrant mitochondrial RNA (Brown
et al. 2003, Komori et al. 2004). These studies indicated
that PPR proteins take part in the post-transcriptional
regulation of organelle gene expression. Most PPR proteins
have been identified in eukaryotic genomes. In particular,
Arabidopsis and rice have several hundred PPR genes in
their genomes, whereas many fewer PPR genes have been
identified from genomes of species other than higher plants
(Lurin et al. 2004). LOI1 is expected to be involved in plant-
specific regulation of isoprenoid biosynthesis in organelles.
The LOI1 protein has the ability to bind ssRNA, especially
G-rich sequences (Fig. 8C), consistent with previous find-
ings for PPR (Lurin et al. 2004). LOI1 may be localized in
mitochondria (Fig. 9). Higher plant mitochondrial genomes
mostly comprise genes encoding subunits of respiratory
chain complexes, rRNA and tRNA (Giegé and Brennicke
1999, Handa 2003). If the expression of these genes is
impaired, it is likely that respiratory electron transport is
affected in loi1. Respiratory electron transport in mitochon-
dria is thought to play an important role in protecting
chloroplasts against photo-inhibition and in energy meta-
bolism in plant cells (Raghavendra and Padmasree 2003).
Given that the side chains of ubiquinone, which act as
electron carriers in the mitochondrial respiratory chain, are
derived from cytosolic IPP, the up-regulation of the MVA
or MEP pathway might arise from any abnormality in these
functions of respiratory electron transport in loi1.
The biological significance of these findings remains to
be elucidated in future experiments, possibly through the
identification of physiological RNA targets.
Although the MVA and MEP pathways are considered
to be highly regulated, there is little knowledge of the
regulatory mechanisms. Here, we reported a novel potential
regulatory locus using analyses of the mutant loi1,
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which shows resistance to inhibitors of the MVA and MEP
pathways. Abnormalities in the post-transcriptional regula-
tion of mitochondrial RNA may affect the isoprenoid
biosynthetic pathway in loi1, probably via the regulation
of HMGR activity. Identification of the target RNA
of LOI1 should lead to a greater understanding of




The loi1 mutant originated from the RIKEN GSC activation
tagged lines (Nakazawa et al. 2003) in the Col-0 background. Seeds
were surface sterilized and germinated on 1 MS (Invitrogen,
Carlsbad, CA, USA) plates containing 3% sucrose and 1.2% agar
(Ina Food Industry, Nagano, Japan). After stratification for at
least 2 d at 48C, plates were incubated at 238C under long-day
conditions (16 h under fluorescent white light, 8 h in the dark).
Lovastatin (Calbiochem, Darmstadt, Germany), clomazone and
squalestatin were dissolved in dimethylsulfoxide and diluted to
different final concentrations in the growth medium.
Analysis of the inhibitor-induced phenotypes
Seedlings grown on solid MS medium supplemented with
lovastatin for 2 weeks were photographed and the root length was
measured. Longitudinal sections of the roots of 2-week-old
seedlings were prepared and examined under a light microscope
as described by Suzuki et al. (2004). Cotyledons of 1-week-old
seedlings were prepared and examined for electron microscopy as
described by Nakanishi et al. (2005).
Extraction and quantification of isoprenoids
Sterols were extracted from freeze-dried plant tissues (2-week-
old seedlings, 10mg) and quantified as described by Suzuki et al.
(2004). Chlorophylls were extracted from freeze-dried plant tissues
(1-week-old seedlings, about 50–100mg) and quantified by
measuring the absorbance at A646 and A663 as described by
Harborne (1998).
Identification of the loi1 mutation
Plasmid rescue was performed to determine the T-DNA
flanking genomic sequences of loi1-1 as described by Ichikawa
et al. (2003). The genomic DNA was digested with BamHI and
SacI. Plasmids containing the genomic DNA were obtained from
self-ligation. Plasmids obtained from the BamHI-digested genomic
DNA were sequenced using the LB4 primer 50-TAGATATCGAT
CGTGAAGTTTCT-30, whereas those obtained from the SacI-
digested genomic DNA were sequenced using the RBI primer
50-ATCTAGATCCGAAACTATCAGTG-30.
Construction of the 35S promoter::LOI1 fusion gene and
transformation of Arabidopsis
The WT LOI1 cDNA fragment amplified using PCR with
the forward primer 50-CACCATGAGCCTCCTCTCCGCGGA-30
and the reverse primer 50-CTCGAGCCAATAATCCTTACAA
GAACATATC-30 was cloned into pENTR/D-TOPO (Invitrogen).
The resultant entry clone was integrated into the binary vector
pBCR-79 (Seki et al. unpublished data) using the GATEWAY
system. The resultant construct was transferred into Agrobacterium
tumefaciens strain GV3101, followed by introduction into loi1-1
homozygous plants using the floral dip method (Clough and Bent
1998).
Analysis of gene expression
For RNA gel blot analysis, 15mg of total RNA from 2-week-
old seedlings was separated on agarose–formaldehyde gels and
blotted to nylon membranes as described by Chomczynski (1992).
To obtain gene-specific probes, the full-length LOI1 cDNA was
cloned into pCRII-TOPO plasmid (Invitrogen). The resultant
plasmid was digested with BamHI, and antisense digoxigenin
(DIG)-labeled single-stranded LOI1 RNA probe was synthesized
by T7 RNA polymerase (Roche, Basel, Switzerland) and DIG
RNA Labeling Mix (Roche). Pre-hybridization, hybridization,
wash conditions and detection were as described by Suzuki et al.
(2004). RT–PCR analysis was performed using the specific





The primers for HMG1, HMG2, DXS1 and elongation factor
were described by Suzuki et al. (2004).
Protein gel blot analysis
Fresh seedlings were homogenized in the extraction buffer
[250mM sucrose, 250mM tricine, 25mM Na2S2O5, 2mM EDTA,
100mM ascorbic acid, 2.5% PVPP, 5mM dithiothreitol (DTT)
and RNase inhibitor; pH8.0]. The homogenate was centrifuged at
200g for 15min at 48C. The supernatant was used as the total
protein fraction. The protein concentration was determined using
Bradford reagent (Bio-Rad, Hercules, CA, USA), with bovine
serum albumin as a standard. A 13mg aliquot of the total protein
was separated by SDS–PAGE and transferred onto nitrocellulose
(Immobilon-P; Millipore Corporation, Millipore, Billerica, MA,
USA). Immunodetection was performed using a 1: 1,000 dilution
of the polyclonal anti-DXS antibodies (Estévez et al. 2000).
Detection was performed by the ECL system (Amersham
Biosciences, Piscataway, NJ, USA) using an anti-mouse immu-
noglobulin conjugated to horseradish peroxidase as a secondary
antibody [anti-mouse IgG (whole molecule) peroxidase conjugate;
Sigma-Ardrich, St Louis, MO, USA].
HMGR enzyme assay
The endoplasmic reticulum protein fraction was prepared and
partially modified as described by Chappell et al. (1995). Total
protein was extracted with the extraction buffer (see protein gel
blot analysis). After centrifugation at 100,000g for 60min at 48C,
the pellet was washed with suspension buffer (250mM sucrose,
100mM tricine, 2mM EDTA and 50mM NaCl; pH7.5) and
suspended in suspension buffer containing 1% Triton X-100 and
10mM DTT. The suspension was rotated for 30min at 48C,
supplemented with 16% glycerol, and then incubated at 378C for
20min. HMGR activity was measured as described by Chappell
et al. (1995).
RNA binding assay of the recombinant LOI1 protein
The sequence coding for LOI1 was cloned into pENTR/
D-TOPO. The resultant plasmid was integrated into GATEWAY-
modified pGEX-5X-1, pBCR-127 (Seki et al. unpublished data).
The recombination reaction product was introduced into E. coli
strain BL21 (Novagen, Madison, WI, USA). Cells were harvested,
resuspended in phosphate-buffered saline (PBS), disrupted using
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an ultrasonic cell disrupter and centrifuged. The purification of
GST–LOI1 and GST–soluble proteins was performed using
glutathione–Sepharose 4B (Amersham Pharmacia, UK). The
binding assay was performed as described by Mili and
Pinol-Roma (2003). The purified GST–LOI1 and GST–StSGT
(Kohara et al. 2005), which was used as a negative control, were
incubated with the Sepharose-bound RNA homopolymer poly(A)
and the agarose-bound RNA homopolymers poly(U), poly(G) and
poly(C), respectively, in 50ml of binding buffer (10mM Tris–HCl
pH8.0, 100mM NaCl, 2.5mM MgCl2, 0.5% Triton X-100, 10%
glycerol, 0.2mM EDTA, 1mM DTT and RNase inhibitor). The
binding reaction mixtures were incubated for 20min at 48C, and
the reaction products were washed three times with the binding
buffer on ice. Bound proteins were separated by SDS–PAGE and
detected by immunoblotting with anti-GST antibody (Nacalai
Tesuque, Kyoto, Japan). An ECLþ system was used for detection
in the immunoblot analysis (Amersham Biosciences).
Transient expression assay of LOI1–GFP
A DNA fragment containing the first 39 amino acid residues
of the LOI1 protein and five residues of the glycine linker was
amplified by PCR using 50-TCTAGAGGATCCATGAGCC
TCCTCTCCGC-30 and 50-ACCACCACCACCACCTGGTGAA
TCGAGGGTTTTGAC-30. The fragment was connected with the
35S promoter and GFP. The resultant fragment was cloned into
the pENTR1A vector (Invitrogen). The resultant entry clone was
integrated into the binary vector pBCR-112 (Seki et al. unpub-
lished data) using the GATEWAY system.
The constructs were transiently transformed into onion
epidermal cells (Scott et al. 1999) on agar plates by a helium-
driven accelerator (PDS/1000; Bio-Rad). Bombardment para-
meters were as follows: 1,100 p.s.i. bombardment pressure,
1.0 mm gold particles, a distance of 6 cm from the macrocarrier to
the samples, and a decompression vacuum of 28 inches Hg.
After culture for 1 d, the bombarded epidermal cells were treated
with 500 nM of the mitochondrion-selective dye MitoTracker
Orange CMTMRos (Invitrogen) in PBS for 10min. After staining,
the onion epidermis was washed with PBS three times. GFP
expression in general and co-localization of GFP fusion proteins to
mitochondria were viewed using a confocal scanning microscope
system (FV500; Olympus, Tokyo, Japan) with 488 nm laser light
for fluorescence excitation of GFP and 543 nm laser light for
excitation of MitoTracker Orange.
Supplementary material
Supplementary material mentioned in the article is
available to online subscribers at the journal website
www.pcp.oxfordjournals.org.
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Giegé, P. and Brennicke, A. (1999) RNA editing in Arabidopsis
mitochondria effects 441C to U changes in ORFs. Proc. Natl Acad.
Sci. USA 96: 15324–15329.
Handa, H. (2003) The complete nucleotide sequence and RNA editing
content of the mitochondrial genome of rapeseed (Brassica napus L.):
comparative analysis of the mitochondrial genomes of rapeseed and
Arabidopsis thaliana. Nucleic Acids Res. 31: 5907–5916.
Harborne, J.B. (1998) Nitrogen compounds. In Phytochemical Methods.
A Guide to Modern Techniques of Plant Analysis, 3rd edn. pp. 227–233.
Springer, Berlin.
Hemmerlin, A., Hoeffler, J.F., Meyer, O., Tritsch, D., Kagan, I.A.,
Grosdemange-Billiard, C., Rohmer, M. and Bach, T.J. (2003) Cross-talk
between the cytosolic mevalonate and the plastidial methylerythritol
phosphate pathways in tobacco bright yellow-2 cells. J. Biol. Chem. 278:
26666–26676.
Ichikawa, T., Nakazawa, M., Kawashima, M., Muto, S., Gohda, K., et al.
(2003) Sequence database of 1172 T-DNA insertion sites in Arabidopsis
activation-tagging lines that showed phenotypes in T1 generation.
Plant J. 36: 421–429.
Kasahara, H., Hanada, A., Kuzuyama, T., Takagi, M., Kamiya, Y. and
Yamaguchi, S. (2002) Contribution of the mevalonate and methylery-
thritol phosphate pathways to the biosynthesis of gibberellins in
Arabidopsis. J. Biol. Chem. 277: 45188–45194.
Kasahara, H., Takei, K., Ueda, N., Hishiyama, S., Yamaya, T.,
Kamiya, Y., Yamaguchi, S. and Sakakibara, H. (2004) Distinct
isoprenoid origins of cis- and trans-zeatin biosyntheses in Arabidopsis.
J. Biol. Chem. 279: 14049–14054.






/pcp/article/48/2/322/2329769 by guest on 08 Septem
ber 2021
Kohara, A., Nakajima, C., Hashimoto, K., Ikenaga, T., Tanaka, H.,
Shoyama, Y., Yoshida, S. and Muranaka, T. (2005) A novel
glucosyltransferase involved in steroid saponin biosynthesis in Solanum
aculeatissimum. Plant Mol. Biol. 57: 225–239.
Komori, T., Ohta, S., Murai, N., Takakura, Y., Kuraya, Y., Suzuki, S.,
Hiei, Y., Imaseki, H. and Nitta, N. (2004) Map-based cloning of
a fertility restorer gene, Rf-1, in rice (Oryza sativa L.). Plant J. 37:
315–325.
Kotera, E., Tasaka, M. and Shikanai, T. (2005) A pentatricopeptide repeat
protein is essential for RNA editing in chloroplasts. Nature 433: 326–330.
Learned, R.M. (1996) Light suppresses 3-hydroxy-3-methylglutaryl
coenzyme A reductase gene expression in Arabidopsis thaliana.
Plant Physiol. 110: 645–655.
Lichtenthaler, H.K. (1999) The 1-deoxy-D-xylulose-5-phosphate pathway of
isoprenoid biosynthesis in plants. Annu. Rev. Plant Physiol. Plant Mol.
Biol. 50: 47–65.
Lurin, C., Andres, C., Aubourg, S., Bellaoui, M., Bitton, F., et al. (2004)
Genome-wide analysis of Arabidopsis pentatricopeptide repeat proteins
reveals their essential role in organelle biogenesis. Plant Cell 16:
2089–2103.
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